TP53 and neoplasm: Specifically, ERG isoforms (detected by Pan-ERG, ERG8, ERG1/ERG2/ERG3, T2-ERG-exon 4 fusion probe sets), TP53 and HDAC1 were found to have a lower tumor vs. normal ratio in cases that progressed to BCR.